Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Canada Goose (GOOS) Beats Stock Market Upswing: What Investors Need to Know
Canada Goose (GOOS) Beats Stock Market Upswing: What Investors Need to Know

In the latest close session, Canada Goose (GOOS) was up +1.42% at $11.46. The stock outperformed the S&P 500, which registered a daily gain of 0.81%. Elsewhere, the Dow saw an upswing of 0.73%

Carnival (CCL) Stock Drops Despite Market Gains: Important Facts to Note
Carnival (CCL) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Carnival (CCL) was down 3.29% at $25.78. This change lagged the S&P 500's 0.81% gain on the day. Elsewhere, the Dow gained 0.73%, while the tech-heavy Nasdaq added

Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why

In the latest close session, Medtronic (MDT) was down 2.76% at $77.79. The stock fell short of the S&P 500, which registered a gain of 0.81% for the day. Meanwhile, the Dow experienced a rise of

Lululemon (LULU) Stock Sinks As Market Gains: Here's Why
Lululemon (LULU) Stock Sinks As Market Gains: Here's Why

Lululemon (LULU) closed the most recent trading day at $130.21, moving -2.52% from the previous trading session. This change lagged the S&P 500's daily gain of 0.81%. Meanwhile, the Dow experienced

Abercrombie & Fitch (ANF) Stock Sinks As Market Gains: What You Should Know
Abercrombie & Fitch (ANF) Stock Sinks As Market Gains: What You Should Know

Abercrombie & Fitch (ANF) ended the recent trading session at $78.52, demonstrating a -7.12% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily

Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Exelixis (EXEL) reported $610.81 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 10%. EPS of $0.87 for the same period compares to $0.62 a year ago.

Crexendo (CXDO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Crexendo (CXDO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Crexendo (CXDO) reported $20.71 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 29%. EPS of $0.10 for the same period compares to $0.08 a year ago.

The

Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say
Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say

Neurocrine Biosciences (NBIX) reported $814.5 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 42.3%. EPS of $1.94 for the same period compares to $0.08

Tempus AI (TEM) Reports Q1 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/da273d82-9e59-413a-99b3-2b0094ff0854.png
Tempus AI (TEM) Reports Q1 Loss, Beats Revenue Estimates

Tempus AI (TEM) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.24 per share a year ago. These figures are

Dentsply International (XRAY) Lags Q1 Earnings Estimates
Dentsply International (XRAY) Lags Q1 Earnings Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.43 per share a year ago

Neurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue Estimates
Neurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $0.08 per share a year ago

Lumen (LUMN) Reports Q1 Loss, Tops Revenue Estimates
Lumen (LUMN) Reports Q1 Loss, Tops Revenue Estimates

Lumen (LUMN) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.13 per share a year ago. These figures are

Skyworks Solutions (SWKS) Q2 Earnings and Revenues Beat Estimates
Skyworks Solutions (SWKS) Q2 Earnings and Revenues Beat Estimates

Skyworks Solutions (SWKS) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.24 per share a year ago. These

Super Micro Computer (SMCI) Beats Q3 Earnings Estimates
Super Micro Computer (SMCI) Beats Q3 Earnings Estimates

Super Micro Computer (SMCI) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.31 per share a year ago

Silicon Laboratories (SLAB) Surpasses Q1 Earnings and Revenue Estimates
Silicon Laboratories (SLAB) Surpasses Q1 Earnings and Revenue Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to a loss of $0.08 per share a year ago. These

Flotek Industries (FTK) Lags Q1 Earnings Estimates
Flotek Industries (FTK) Lags Q1 Earnings Estimates

Flotek Industries (FTK) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.17 per share a year ago. These

Emerson Electric (EMR) Meets Q2 Earnings Estimates
Emerson Electric (EMR) Meets Q2 Earnings Estimates

Emerson Electric (EMR) came out with quarterly earnings of $1.54 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.48 per share a year ago. These figures are

Lumentum (LITE) Q3 Earnings and Revenues Top Estimates
Lumentum (LITE) Q3 Earnings and Revenues Top Estimates

Lumentum (LITE) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.24 per share. This compares to earnings of $0.57 per share a year ago. These figures

Gulfport Energy (GPOR) Lags Q1 Earnings Estimates
Gulfport Energy (GPOR) Lags Q1 Earnings Estimates

Gulfport Energy (GPOR) came out with quarterly earnings of $7.28 per share, missing the Zacks Consensus Estimate of $7.72 per share. This compares to earnings of $5.58 per share a year ago. These

Exelixis (EXEL) Tops Q1 Earnings Estimates
Exelixis (EXEL) Tops Q1 Earnings Estimates

Exelixis (EXEL) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.62 per share a year ago. These figures

DaVita HealthCare (DVA) Tops Q1 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
DaVita HealthCare (DVA) Tops Q1 Earnings and Revenue Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.41 per share. This compares to earnings of $2 per share a year ago. These

Devon Energy (DVN) Surpasses Q1 Earnings Estimates
Devon Energy (DVN) Surpasses Q1 Earnings Estimates

Devon Energy (DVN) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $1.21 per share a year ago. These figures

AtriCure (ATRC) Reports Break-Even Earnings for Q1
AtriCure (ATRC) Reports Break-Even Earnings for Q1

AtriCure (ATRC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.14 per share a year ago. These figures are

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $1.17. This compares to a loss of $0.82 per share a year ago

Arista Networks (ANET) Beats Q1 Earnings and Revenue Estimates
Arista Networks (ANET) Beats Q1 Earnings and Revenue Estimates

Arista Networks (ANET) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.65 per share a year ago. These